✦ LIBER ✦
Use of MLL/GRAF fusion mRNA for measurement of minimal residual disease during chemotherapy in an infant with acute monoblastic leukemia (AML-M5)
✍ Scribed by Monika Wilda; Antje Vega Perez; Jochen Bruch; Wilhelm Woessmann; Markus Metzler; Uta Fuchs; Arndt Borkhardt
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 103 KB
- Volume
- 43
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.